DK13087A - Gensekvens til fremstilling af human serumalbumin i bacillus - Google Patents

Gensekvens til fremstilling af human serumalbumin i bacillus

Info

Publication number
DK13087A
DK13087A DK013087A DK13087A DK13087A DK 13087 A DK13087 A DK 13087A DK 013087 A DK013087 A DK 013087A DK 13087 A DK13087 A DK 13087A DK 13087 A DK13087 A DK 13087A
Authority
DK
Denmark
Prior art keywords
revenue
bacillus
manufacture
serum albumin
human serum
Prior art date
Application number
DK013087A
Other languages
English (en)
Other versions
DK13087D0 (da
Inventor
Charles Winston Saunders
Mark Samuel Guyer
Original Assignee
Genex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genex Corp filed Critical Genex Corp
Publication of DK13087D0 publication Critical patent/DK13087D0/da
Publication of DK13087A publication Critical patent/DK13087A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411Amylases
    • C12N9/2414Alpha-amylase (3.2.1.1.)
    • C12N9/2417Alpha-amylase (3.2.1.1.) from microbiological source
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK013087A 1986-01-13 1987-01-12 Gensekvens til fremstilling af human serumalbumin i bacillus DK13087A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82464286A 1986-01-13 1986-01-13

Publications (2)

Publication Number Publication Date
DK13087D0 DK13087D0 (da) 1987-01-12
DK13087A true DK13087A (da) 1987-07-14

Family

ID=25241943

Family Applications (1)

Application Number Title Priority Date Filing Date
DK013087A DK13087A (da) 1986-01-13 1987-01-12 Gensekvens til fremstilling af human serumalbumin i bacillus

Country Status (6)

Country Link
EP (1) EP0229712A3 (da)
JP (1) JPS62215393A (da)
KR (1) KR870007280A (da)
AU (1) AU585422B2 (da)
DK (1) DK13087A (da)
FI (1) FI870103A (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89992A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of human serum albumin in methylotrophic yeasts
FR2649991B2 (fr) 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
CN1066486C (zh) * 1989-06-22 2001-05-30 霍夫曼-拉罗奇有限公司 高产核黄素的细菌菌株
US5837528A (en) 1989-06-22 1998-11-17 Hoffmann La Roche, Inc. Bacterial strains which overproduce riboflavin
JPH0671432B2 (ja) * 1991-03-20 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JPH07308199A (ja) 1994-05-18 1995-11-28 Green Cross Corp:The ヒト血清アルブミンの製造方法
BRPI0912663A2 (pt) 2008-05-15 2016-01-26 R Tech Ueno Ltd composição farmacêutica para o tratamento de olho seco e/ou lesão corneal e conjuntival

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419450A (en) * 1982-04-21 1983-12-06 Cpc International Inc. Plasmid cloning vector for Bacillus subtilis
US4713339A (en) * 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
CA1311429C (en) * 1983-07-06 1992-12-15 Vasantha Nagarajan Vector for polypeptides in bacilli
JPS6087792A (ja) * 1983-09-23 1985-05-17 ジェネックス・コーポレイション 雑種制御領域
GB8510219D0 (en) * 1985-04-22 1985-05-30 Bass Plc Isolation of fermentation products

Also Published As

Publication number Publication date
EP0229712A3 (en) 1988-11-09
FI870103A0 (fi) 1987-01-12
AU585422B2 (en) 1989-06-15
AU6751987A (en) 1987-07-16
KR870007280A (ko) 1987-08-18
FI870103A (fi) 1987-07-14
EP0229712A2 (en) 1987-07-22
DK13087D0 (da) 1987-01-12
JPS62215393A (ja) 1987-09-22

Similar Documents

Publication Publication Date Title
DK0464590T3 (da) Hindring af farvning af humant serumalbumin
DK0570916T3 (da) Fremgangsmåde til rensning af humant rekombinant serumalbumin
DK254688A (da) Fremgangsmaade til fremstilling af folininsyre
DK0420007T3 (da) Fremgangsmåde til rensning af human serumalbumin
DK237187A (da) Farmaceutisk anvendelse af t-pa
DK22387D0 (da) Fremgangsmaade til fremstilling af ethanol
DK168190A (da) Interferonpraeparat til nasal anvendelse
DK281789A (da) Fremgangsmaade til fremstilling af riboflavin i form af granulater
DK0656419T3 (da) Fremgangsmåde til højrensning af humant serumalbumin
DK13087D0 (da) Gensekvens til fremstilling af human serumalbumin i bacillus
DK0504823T3 (da) Fremgangsmåde til fremstilling af human serumalbumin
DK271588A (da) Genteknologisk fremgangsmaade til fremstilling af angiogeniner
DK249090A (da) Anvendelse af glycoproteiner til fremstilling af haarpraeparater
DK100289A (da) Fremgangsmaade til fremstilling af n-sulfonylurinstoffer
DK309789D0 (da) Fremgangsmaade til fremstilling af alumoxaner
DK0655503T3 (da) Fremgangsmåde til fremstilling af humant serumalbumin
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK315789A (da) Fremgangsmaade til fremstilling af halogenerede sulfoner
NO881942L (no) Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten.
FI870765A0 (fi) Anordning foer inriktning av styckealster i frammatningsenheter hos aggregat.
IT8720352A0 (it) Sostanza profilattica e terapeutica per disturbi epatici.
FR2615369B1 (fr) Chaise-canne
KR870015914U (ko) 의자
DK162789D0 (da) Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
DK320489A (da) Fremgangsmaade til diagnosticering af down's syndrom